EKF Diagnostics Holdings plc (LON:EKF - Get Free Report)'s stock price was up 12.3% during trading on Tuesday . The stock traded as high as GBX 23.77 ($0.31) and last traded at GBX 23.02 ($0.30). Approximately 3,099,554 shares were traded during mid-day trading, an increase of 555% from the average daily volume of 473,495 shares. The stock had previously closed at GBX 20.50 ($0.27).
EKF Diagnostics Stock Performance
The stock has a 50 day simple moving average of GBX 23.04 and a 200 day simple moving average of GBX 25.76. The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. The company has a market cap of £97.34 million, a price-to-earnings ratio of 20.38 and a beta of 0.57.
EKF Diagnostics (LON:EKF - Get Free Report) last released its quarterly earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. As a group, analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.
Insiders Place Their Bets
In other news, insider Gavin T. Jones bought 50,000 shares of the firm's stock in a transaction dated Tuesday, March 25th. The stock was bought at an average price of GBX 22 ($0.28) per share, for a total transaction of £11,000 ($14,237.64). 5.24% of the stock is owned by company insiders.
About EKF Diagnostics
(
Get Free Report)
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Featured Articles
Before you consider EKF Diagnostics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EKF Diagnostics wasn't on the list.
While EKF Diagnostics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
